Back to search
FDAFDA · Food and drugs·Recall number D-0043-2025

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Published November 20, 2024 · Recall initiated: October 23, 2024

Summary

FDA records drug Class II recall D-0043-2025, published November 20, 2024 and initiated October 23, 2024. Recalling firm: Cipla USA, Inc.; Status: Ongoing; Reported quantity: 1,875 boxes (cipla and exlan); Lot: Lot # NB240316, Exp 12/31/25. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cipla USA, Inc.
Distributor
USA nationwide.
Lot
Lot # NB240316, Exp 12/31/25
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98 recalled?

Yes. FDA published recall D-0043-2025 on November 20, 2024. Reported hazard: Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter